Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $22.10 USD
Change Today -0.40 / -1.78%
Volume 993.0K
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Connie L. Matsui

Independent Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee, Halozyme Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 57 board members in 2 different organizations across 2 different industries.

See Board Relationships
61$271,253

Background*

Ms. Connie L. Matsui served as an Executive Vice President of Corporate Strategy and Communication at Biogen Idec Inc. since November, 2003. Ms. Matsui served as an Senior Vice President, Planning and Resource Development at Biogen Idec Inc. from September 2000 to November 2003. She joined Idec Pharmaceuticals Corp. in November 1992 as Senior Director, Planning and Resource Development with primary responsibility for strategic planning and human resources. She served ...

Read Full Background

Corporate Headquarters*

11388 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-794-8889
Fax: 858-704-8311

Board Members Memberships*

2006-Present
Independent Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee

Education*

BA
Stanford University
MBA
Stanford University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$71,250
Total Calculated Compensation$271,253
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $22.10 USD -0.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.